• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依维莫司洗脱支架与紫杉醇洗脱支架治疗小冠状动脉疾病的血管反应差异:光学相干断层扫描分析

Difference of vascular response between everolimus- and paclitaxel-eluting stents for small coronary artery disease: Optical coherence tomography analysis.

作者信息

Nasu Kenya, Oikawa Yuji, Aizawa Tadanori, Suzuki Takahiko

机构信息

Department of Cardiology, Toyohashi Heart Center, Aichi, Japan.

Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan.

出版信息

Int J Cardiol Heart Vessel. 2014 Feb 8;3:21-27. doi: 10.1016/j.ijchv.2014.01.001. eCollection 2014 Jun.

DOI:10.1016/j.ijchv.2014.01.001
PMID:29450165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5801262/
Abstract

BACKGROUND

Previous clinical trials have demonstrated the clinical and angiographic superiority of everolimus-eluting stents (EES) compared with paclitaxel-eluting stents (PES) in the small coronary vessel. However, the differences of vascular response including assessment of morphological neointimal tissue (NIT) characteristics using optical coherence tomography (OCT) have not been fully evaluated. The aim of this study is to evaluate the differences of chronic vascular response following small coronary stenting between EES and PES using OCT.

METHODS AND RESULTS

A prospective OCT examination at 9 month follow-up was performed for 50 small coronary artery diseases (50 patients) treated by a single 2.5 mm stent for each stent group. Cross-sectional area within stent segments were analyzed at an interval of 1 mm. NIT structure (homogeneous or heterogeneous) was evaluated for qualitative assessment. Homogeneous NIT was observed significantly higher and heterogeneous NIT was lower in EES compared with PES (93% vs. 89%; p = 0.003, 6.5% vs. 10.3%; p = 0.002, respectively). The frequencies of exposed and malapposed struts were lower in EES compared with PES (0.2% vs. 1.7%; p = 0.0001, 0.1% vs. 0.3%; p = 0.001, respectively). NIT eccentricity index and NIT area were lower in EES compared with PES (0.69 ± 0.08 vs. 0.76 ± 0.10; p = 0.001, 0.97 ± 0.42 mm vs. 1.27 ± 0.67 mm; p = 0.01, respectively).

CONCLUSIONS

A favorable vascular response was observed after EES implantation compared with PES for small coronary artery disease. In addition, the characteristics of NIT after EES implantation were more stable than PES at 9 month follow-up.

摘要

背景

既往临床试验已证明,在小冠状动脉血管中,依维莫司洗脱支架(EES)在临床和血管造影方面优于紫杉醇洗脱支架(PES)。然而,包括使用光学相干断层扫描(OCT)评估形态学新生内膜组织(NIT)特征在内的血管反应差异尚未得到充分评估。本研究的目的是使用OCT评估EES和PES在小冠状动脉支架置入术后慢性血管反应的差异。

方法与结果

对每个支架组中接受单个2.5mm支架治疗的50例小冠状动脉疾病患者(共50例)进行了9个月随访时的前瞻性OCT检查。以1mm的间隔分析支架节段内的横截面积。对NIT结构(均匀或不均匀)进行定性评估。与PES相比,EES中观察到均匀NIT的比例显著更高,不均匀NIT的比例更低(分别为93%对89%;p = 0.003,6.5%对10.3%;p = 0.002)。与PES相比,EES中暴露和贴壁不良支架的频率更低(分别为0.2%对1.7%;p = 0.0001,0.1%对0.3%;p = 0.001)。与PES相比,EES的NIT偏心指数和NIT面积更低(分别为0.69±0.08对0.76±0.10;p = 0.001,0.97±0.42mm对1.27±0.67mm;p = 0.01)。

结论

对于小冠状动脉疾病,与PES相比,EES植入后观察到了良好的血管反应。此外,在9个月随访时,EES植入后NIT的特征比PES更稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb24/5801262/5a0313e1874c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb24/5801262/5111a661a4bf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb24/5801262/8dd2444cd06e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb24/5801262/5a0313e1874c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb24/5801262/5111a661a4bf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb24/5801262/8dd2444cd06e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb24/5801262/5a0313e1874c/gr3.jpg

相似文献

1
Difference of vascular response between everolimus- and paclitaxel-eluting stents for small coronary artery disease: Optical coherence tomography analysis.依维莫司洗脱支架与紫杉醇洗脱支架治疗小冠状动脉疾病的血管反应差异:光学相干断层扫描分析
Int J Cardiol Heart Vessel. 2014 Feb 8;3:21-27. doi: 10.1016/j.ijchv.2014.01.001. eCollection 2014 Jun.
2
Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents.冠状动脉光学相干断层成像术评价依维莫司洗脱支架 6 个月随访结果:与紫杉醇洗脱支架比较。
Int J Cardiol. 2013 Jun 5;166(1):181-6. doi: 10.1016/j.ijcard.2011.10.102. Epub 2011 Nov 8.
3
Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.第一代药物洗脱支架与依维莫司洗脱支架晚期支架覆盖模式的光学相干断层扫描评估
Catheter Cardiovasc Interv. 2014 Nov 1;84(5):720-6. doi: 10.1002/ccd.25235. Epub 2013 Oct 31.
4
Longitudinal Neointimal Distribution Pattern After Everolimus-Eluting Stent Implantation: Insights From Optical Coherence Tomography Study.依维莫司洗脱支架置入后的纵向新生内膜分布模式:光学相干断层扫描研究的新发现。
Cardiovasc Revasc Med. 2021 May;26:17-23. doi: 10.1016/j.carrev.2020.10.020. Epub 2020 Nov 1.
5
Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.光学相干断层扫描检测不同类型第二代药物洗脱支架植入后血管反应的比较
Int J Cardiovasc Imaging. 2017 Feb;33(2):177-186. doi: 10.1007/s10554-016-1001-2. Epub 2016 Oct 19.
6
Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.使用光学相干断层扫描比较西罗莫司洗脱支架和依维莫司洗脱支架的新生内膜覆盖情况及支架外管腔情况。
Heart Vessels. 2016 Apr;31(4):449-56. doi: 10.1007/s00380-015-0630-z. Epub 2015 Jan 23.
7
Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.急性冠状动脉综合征患者的药物洗脱支架植入术——抑制血小板活性与心血管事件:光学相干断层扫描(APICE OCT)研究。
EuroIntervention. 2014 Dec;10(8):916-23. doi: 10.4244/EIJY14M06_10.
8
Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.支架置入 9 个月后,依维莫司洗脱支架的新生内膜覆盖良好:与光学相干断层成像术比较,雷帕霉素洗脱支架。
Int J Cardiovasc Imaging. 2012 Mar;28(3):491-7. doi: 10.1007/s10554-011-9849-7. Epub 2011 Mar 26.
9
Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography.紫杉醇洗脱支架与依维莫司洗脱支架同期植入同一冠状动脉内不同病变的比较:光学相干断层成像术 12 个月随访结果。
EuroIntervention. 2013 Dec;9(8):952-8. doi: 10.4244/EIJV9I8A159.
10
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.经皮冠状动脉介入治疗后病变长度和血管大小对临床结局的影响:来自 SPIRIT(依维莫司洗脱冠状动脉支架系统 XIENCE V 的临床评估)和 COMPARE(真实世界中第二代依维莫司洗脱和紫杉醇洗脱支架)随机试验的汇总分析。
JACC Cardiovasc Interv. 2011 Nov;4(11):1209-15. doi: 10.1016/j.jcin.2011.07.016.

本文引用的文献

1
Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.基于连续 OCT 的 DES 相关新生内膜组织的定量和定性变化。
JACC Cardiovasc Imaging. 2012 Nov;5(11):1147-55. doi: 10.1016/j.jcmg.2012.01.024.
2
ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).使用光学相干断层扫描(COVER OCT)比较佐他莫司洗脱支架和依维莫司洗脱支架的新生内膜覆盖率。
Am Heart J. 2012 Apr;163(4):601-7. doi: 10.1016/j.ahj.2011.10.016.
3
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
经皮冠状动脉介入治疗后病变长度和血管大小对临床结局的影响:来自 SPIRIT(依维莫司洗脱冠状动脉支架系统 XIENCE V 的临床评估)和 COMPARE(真实世界中第二代依维莫司洗脱和紫杉醇洗脱支架)随机试验的汇总分析。
JACC Cardiovasc Interv. 2011 Nov;4(11):1209-15. doi: 10.1016/j.jcin.2011.07.016.
4
Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents.冠状动脉光学相干断层成像术评价依维莫司洗脱支架 6 个月随访结果:与紫杉醇洗脱支架比较。
Int J Cardiol. 2013 Jun 5;166(1):181-6. doi: 10.1016/j.ijcard.2011.10.102. Epub 2011 Nov 8.
5
Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trials.在小血管中,依维莫司洗脱支架与紫杉醇洗脱支架的性能比较:来自 SPIRIT III 和 SPIRIT IV 临床试验的结果。
J Interv Cardiol. 2011 Dec;24(6):505-13. doi: 10.1111/j.1540-8183.2011.00664.x. Epub 2011 Sep 15.
6
Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.药物洗脱支架置入后支架内新动脉粥样硬化的光学相干断层成像分析。
Circulation. 2011 Jun 28;123(25):2954-63. doi: 10.1161/CIRCULATIONAHA.110.988436. Epub 2011 Jun 6.
7
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes.血管紧张素转换酶抑制通过内皮祖细胞调节急性冠状动脉综合征患者的内皮细胞凋亡和更新。
Am J Cardiovasc Drugs. 2011 Jun 1;11(3):189-98. doi: 10.2165/11589400-000000000-00000.
8
Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study.支架植入术后早期和极晚期再狭窄病变组织特征的差异:光学相干断层成像研究。
Circ Cardiovasc Interv. 2011 Jun;4(3):232-8. doi: 10.1161/CIRCINTERVENTIONS.110.959999. Epub 2011 May 24.
9
Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.支架置入 9 个月后,依维莫司洗脱支架的新生内膜覆盖良好:与光学相干断层成像术比较,雷帕霉素洗脱支架。
Int J Cardiovasc Imaging. 2012 Mar;28(3):491-7. doi: 10.1007/s10554-011-9849-7. Epub 2011 Mar 26.
10
The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents.人类冠状动脉植入物中金属裸支架和药物洗脱支架的新生动脉粥样硬化的病理学。
J Am Coll Cardiol. 2011 Mar 15;57(11):1314-22. doi: 10.1016/j.jacc.2011.01.011.